WebAug 15, 2024 · Second Quarter Ended June 30, 2024 Financial and Operating Results. Revenue totaled $2.9 million for the three months ended June 30, 2024, which represents a contraction of 18.1%, or $0.6 million ... WebReShape Medical General Information. Description. Developer of an integrated gastric dual balloon system designed to transform weight loss. The company's dual balloon system is …
ReShape Lifesciences Announces 1-for-50 Reverse Stock RSLS …
WebApr 11, 2024 · Trading volume for Reshape Lifesciences's stock is 2.3 million as of 13:30 EST. This is 371.7% of its average full-day volume over the last 100 days. The company's … WebApr 11, 2024 · ReShape Lifesciences (NASDAQ:RSLS) has received a notice of allowance from the U.S. patent office for a patent application related to its Obalon balloon system.The patent will cover additional ... fwc early teal season
Head to Head Review: ReShape Lifesciences (OTCMKTS:RSLS) …
WebApr 11, 2024 · ReShape Lifesciences has a beta of -0.05, suggesting that its stock price is 105% less volatile than the S&P 500. ... ReShape Lifesciences, Inc. is a medical device company, ... WebFind the latest ReShape Lifesciences Inc. (RSLS) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest ReShape Lifesciences Inc. (RSLS) stock discussion in Yahoo … Discover historical prices for RSLS stock on Yahoo Finance. View daily, weekly or … Find out the direct holders, institutional holders and mutual fund holders for … Description. ReShape Lifesciences Inc., a medical device company, provides … See ReShape Lifesciences Inc. (RSLS) stock analyst estimates, including earnings and … See ReShape Lifesciences Inc. (RSLS) Environment, Social and Governance … Find the latest ReShape Lifesciences Inc. (RSLS) stock quote, history, news and … Find out all the key statistics for ReShape Lifesciences Inc. (RSLS), including … WebApr 11, 2024 · April 11, 2024 - 8:30 am. SAN CLEMENTE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for … fwce nmsu